Loading
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Previous close
$1.52
+$0.01 · +0.66%
After-hours
$1.55
+$0.03 · +1.97%
Oct 8, 7:30 PM ET
Regular session · ET · Market data may be delayed.
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Day range
Current $1.52
52-week range
Current $1.52
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
10
Overpriced
Sentiment
50
Mixed
Risk
63
High Risk
Momentum
17
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Day range
Current $1.52
52-week range
Current $1.52
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 2.2M USD | 3.36M USD | 878.97K USD |
| Cost of goods sold | 1.42M USD | 1.43M USD | 140.96K USD |
| Gross profit | 775.06K USD | 1.93M USD | 738.01K USD |
| Research and development | 2.07M USD | 2.02M USD | — |
| Selling, general, and administrative | 2.54M USD | 1.11M USD | 641.18K USD |
| Operating expenses | 4.61M USD | 3.13M USD | 641.18K USD |
| Interest income | 40.3K USD | 45.3K USD | 1.61K USD |
| Depreciation and amortization | 93.69K USD | 47.25K USD | 37.19K USD |
| Operating income | −3.84M USD | −1.2M USD | 96.83K USD |
| Net income | −3.82M USD | −1.19M USD | 399.04K USD |
Company facts updated Oct 9, 2026.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
